State of Alaska Department of Revenue Buys 11,883 Shares of The Cooper Companies, Inc. $COO

State of Alaska Department of Revenue lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 52.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,368 shares of the medical device company’s stock after buying an additional 11,883 shares during the period. State of Alaska Department of Revenue’s holdings in Cooper Companies were worth $2,355,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Cooper Companies by 48.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after purchasing an additional 7,363 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Cooper Companies by 33.7% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,191 shares of the medical device company’s stock worth $85,000 after purchasing an additional 300 shares during the last quarter. Czech National Bank increased its stake in shares of Cooper Companies by 6.6% in the second quarter. Czech National Bank now owns 48,882 shares of the medical device company’s stock worth $3,478,000 after buying an additional 3,041 shares during the period. Alecta Tjanstepension Omsesidigt raised its holdings in Cooper Companies by 60.7% during the 2nd quarter. Alecta Tjanstepension Omsesidigt now owns 1,349,500 shares of the medical device company’s stock valued at $96,030,000 after buying an additional 509,800 shares during the last quarter. Finally, Mn Services Vermogensbeheer B.V. boosted its position in Cooper Companies by 2.5% during the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 73,508 shares of the medical device company’s stock valued at $5,231,000 after buying an additional 1,800 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Trading Down 1.8%

COO opened at $81.70 on Wednesday. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $100.24. The stock has a market cap of $16.01 billion, a PE ratio of 43.46, a PEG ratio of 2.38 and a beta of 1.03. The business has a 50 day moving average of $78.45 and a 200-day moving average of $73.52.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its board has initiated a stock repurchase program on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the medical device company to buy up to 15.4% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Barclays restated an “overweight” rating and issued a $91.00 price objective on shares of Cooper Companies in a research report on Monday, December 8th. Wells Fargo & Company upped their price target on Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a research report on Friday, December 5th. JPMorgan Chase & Co. lifted their price objective on Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research report on Friday, December 5th. Needham & Company LLC restated a “buy” rating and set a $100.00 target price (up previously from $94.00) on shares of Cooper Companies in a report on Friday, December 5th. Finally, The Goldman Sachs Group reaffirmed a “sell” rating and issued a $73.00 price target on shares of Cooper Companies in a research note on Friday. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $90.31.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, insider Holly R. Sheffield acquired 1,230 shares of the business’s stock in a transaction on Tuesday, December 16th. The shares were acquired at an average price of $80.75 per share, for a total transaction of $99,322.50. Following the completion of the acquisition, the insider owned 39,052 shares in the company, valued at $3,153,449. This trade represents a 3.25% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Cynthia L. Lucchese bought 1,784 shares of the stock in a transaction dated Monday, December 22nd. The shares were acquired at an average price of $84.06 per share, with a total value of $149,963.04. Following the completion of the acquisition, the director directly owned 9,445 shares of the company’s stock, valued at approximately $793,946.70. The trade was a 23.29% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 16,014 shares of company stock valued at $1,304,416 over the last three months. 1.98% of the stock is currently owned by corporate insiders.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.